Pulmonary interleukin 1 beta/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation

Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Orthotopic liver tumor models and RNA-Seq...

Full description

Saved in:
Bibliographic Details
Published inJournal of experimental & clinical cancer research Vol. 42; no. 1; p. 166
Main Authors Zhang, Chong, Li, Qing, Xu, Qi, Dong, Wei, Li, Chunmei, Deng, Bin, Gong, Jiao, Zhang, Li-Zhen, Jin, Junfei
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 13.07.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Orthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b ) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1β)/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. Accumulation of myeloid cells and upregulation of IL-1β were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1β. Overexpression of SAA3 in the lungs of Il1b mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1β dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. Our study suggests a key role of pulmonary IL-1β and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
AbstractList BackgroundIncreasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown.MethodsOrthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b−/−) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1β)/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining.ResultsAccumulation of myeloid cells and upregulation of IL-1β were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b−/− mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1β. Overexpression of SAA3 in the lungs of Il1b−/− mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1β dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells.ConclusionsOur study suggests a key role of pulmonary IL-1β and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
Background Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Methods Orthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b.sup.-/-) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1[beta])/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. Results Accumulation of myeloid cells and upregulation of IL-1[beta] were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b.sup.-/- mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1[beta]. Overexpression of SAA3 in the lungs of Il1b.sup.-/- mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1[beta] dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. Conclusions Our study suggests a key role of pulmonary IL-1[beta] and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC. Keywords: IL-1[beta], SAA3, MMP9, HCC, Pre-metastatic niche
Abstract Background Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Methods Orthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout ( Il1b −/− ) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1β)/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. Results Accumulation of myeloid cells and upregulation of IL-1β were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b −/− mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1β. Overexpression of SAA3 in the lungs of Il1b −/− mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1β dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. Conclusions Our study suggests a key role of pulmonary IL-1β and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
Abstract Background Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Methods Orthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b −/− ) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1β)/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. Results Accumulation of myeloid cells and upregulation of IL-1β were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b −/− mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1β. Overexpression of SAA3 in the lungs of Il1b −/− mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1β dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. Conclusions Our study suggests a key role of pulmonary IL-1β and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Orthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b.sup.-/-) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1[beta])/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. Accumulation of myeloid cells and upregulation of IL-1[beta] were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b.sup.-/- mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1[beta]. Overexpression of SAA3 in the lungs of Il1b.sup.-/- mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1[beta] dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. Our study suggests a key role of pulmonary IL-1[beta] and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
BACKGROUNDIncreasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. METHODSOrthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b-/-) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1β)/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. RESULTSAccumulation of myeloid cells and upregulation of IL-1β were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b-/- mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1β. Overexpression of SAA3 in the lungs of Il1b-/- mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1β dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. CONCLUSIONSOur study suggests a key role of pulmonary IL-1β and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic niche is formed and promotes pulmonary metastasis of hepatocellular carcinoma (HCC) remains unknown. Orthotopic liver tumor models and RNA-Seq were used to identify dysregulated genes in the pre-metastatic lung. Il1b knockout (Il1b ) mice and lentivirus-mediated gene knockdown/overexpression were utilized to demonstrate the role of interleukin 1 beta (IL-1β)/serum amyloid A3 (SAA3) in the pre-metastatic niche formation and pulmonary metastasis. The potential molecular mechanisms were investigated by RNA-Seq, real-time quantitative PCR (qPCR), western blotting, immunohistochemistry (IHC), flow cytometry, luciferase reporter assay, double immunofluorescent staining and H&E staining. Accumulation of myeloid cells and upregulation of IL-1β were observed in the pre-metastatic lung of orthotopic liver tumor models. Myeloid cells accumulation and pulmonary metastasis were suppressed in Il1b mice and Il1r1-silencing mice. Mechanistically, SAA3 and matrix metallopeptidase 9 (MMP9) were identified as potential downstream targets of IL-1β. Overexpression of SAA3 in the lungs of Il1b mice restored myeloid cells accumulation and pulmonary metastasis of the orthotopic HCC xenografts. Moreover, alveolar macrophages-derived IL-1β dramatically enhanced SAA3 expression in alveolar epithelial cells in an NF-κB dependent manner and increased MMP9 levels in an autocrine manner. Furthermore, SAA3 recruited myeloid cells to the lung without affecting the expression of MMP9 in myeloid cells. Our study suggests a key role of pulmonary IL-1β and SAA3 in creating a permissive lung pre-metastatic niche by enhancing MMP9 expression and recruiting myeloid cells, respectively, thus promoting pulmonary metastasis of HCC.
ArticleNumber 166
Audience Academic
Author Jin, Junfei
Li, Qing
Xu, Qi
Li, Chunmei
Deng, Bin
Gong, Jiao
Zhang, Chong
Dong, Wei
Zhang, Li-Zhen
Author_xml – sequence: 1
  givenname: Chong
  surname: Zhang
  fullname: Zhang, Chong
  organization: China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin, 541001, Guangxi, China
– sequence: 2
  givenname: Qing
  surname: Li
  fullname: Li, Qing
  organization: China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin, 541001, Guangxi, China
– sequence: 3
  givenname: Qi
  surname: Xu
  fullname: Xu, Qi
  organization: Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China
– sequence: 4
  givenname: Wei
  surname: Dong
  fullname: Dong, Wei
  organization: Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China
– sequence: 5
  givenname: Chunmei
  surname: Li
  fullname: Li, Chunmei
  organization: China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin, 541001, Guangxi, China
– sequence: 6
  givenname: Bin
  surname: Deng
  fullname: Deng, Bin
  organization: China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin, 541001, Guangxi, China
– sequence: 7
  givenname: Jiao
  surname: Gong
  fullname: Gong, Jiao
  organization: Department of Laboratory Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, Guangdong, China
– sequence: 8
  givenname: Li-Zhen
  surname: Zhang
  fullname: Zhang, Li-Zhen
  email: zhanglzh3@mail2.sysu.edu.cn
  organization: Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, Guangdong, China. zhanglzh3@mail2.sysu.edu.cn
– sequence: 9
  givenname: Junfei
  surname: Jin
  fullname: Jin, Junfei
  email: junfeijin@glmc.edu.cn, junfeijin@glmc.edu.cn, junfeijin@glmc.edu.cn, junfeijin@glmc.edu.cn
  organization: China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin, 541001, Guangxi, China. junfeijin@glmc.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37443052$$D View this record in MEDLINE/PubMed
BookMark eNptUl2P1CAUbcwa90P_gA-GxMT40l0obSlPZrPxY5NN9EGfyS29zDBSGKHdOH_FXyuzM64zxgApvfecAz0958WJDx6L4iWjl4x17VVinNZtSSuel6i7sn5SnDHRtKWUbXtysD8tzlNaUdoyyeSz4pSLuua0qc6KX19mNwYPcUOsnzA6nL9bTxjpcYKrhHEeCYwbF-xArjmBnzaRdQxjmDARN_sFGTMw5ZkbwZAlrmEKGp2bHUSiIWrrwwik3xAD2jo7wWQzbVpiFsJyT5-sJt7qXDQhjvk1-OfFUwMu4Yv986L49uH915tP5d3nj7c313elbmQzlaLlmmMHOEDDNEop-rruuREtNRxlV2kqdD8gItW1yY0BzWA48N5o6GvNL4rbne4QYKXW0Y7ZDRXAqodCiAsFMd_PoWqY6GhnulYgrSVg30pDgVeVhg5p1Wetdzut9dyPOGj0UwR3JHrc8XapFuFeMcq5rDuRFd7uFWL4MWOa1GjT1k_wGOakqo53VUO54Bn6-h_oKszRZ68eUKLjrWj-ohaQv8B6E_LBeiuqrkUjGJUVlRl1-R9UHgOOVufcGZvrR4Q3B4QlgpuWKbh5--fSMbDaAXUMKUU0j24wqrY5Vrscq5xj9ZBjVWfSq0MfHyl_gst_AwPT8zQ
CitedBy_id crossref_primary_10_4251_wjgo_v16_i5_1676
crossref_primary_10_1177_10732748241236333
crossref_primary_10_1016_j_lfs_2024_122539
Cites_doi 10.1182/blood-2007-01-068031
10.26508/lsa.201800226
10.1002/eji.201041037
10.4049/jimmunol.1403215
10.1016/j.ccr.2014.03.007
10.1016/j.ccell.2016.06.021
10.1073/pnas.0437939100
10.1038/nature04186
10.1089/omi.2011.0118
10.1002/eji.201343867
10.1158/0008-5472.CAN-10-0706
10.1038/s41572-020-00240-3
10.1016/j.ccr.2008.11.012
10.1371/journal.pone.0005842
10.1084/jem.20181170
10.1038/nature07623
10.1016/j.cmet.2022.11.003
10.1073/pnas.1717802115
10.1158/1078-0432.CCR-20-1610
10.1038/nrc.2017.6
10.1016/j.ccell.2021.04.011
10.1016/j.cell.2008.01.046
10.1016/j.ccell.2016.09.011
10.1038/ncb1794
10.1016/j.ejmech.2020.112260
10.1161/res.90.3.251
10.1186/s13059-014-0550-8
10.1038/onc.2013.568
10.1016/j.yexcr.2019.05.035
10.1111/imr.12614
10.1016/S1535-6108(02)00153-8
10.3390/cancers12020433
10.1038/s41591-020-01195-4
10.1016/j.semcancer.2022.05.002
10.1016/S0140-6736(17)32247-X
10.1093/bioinformatics/btq675
10.1073/pnas.2201899119
10.1016/j.immuni.2022.07.001
10.1158/0008-5472.CAN-19-2288
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13046-023-02748-4
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

CrossRef



MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Open Access: DOAJ - Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-9966
EndPage 166
ExternalDocumentID oai_doaj_org_article_517808f867e049aeb69f0a322ca8e02b
A757109209
10_1186_s13046_023_02748_4
37443052
Genre Journal Article
GeographicLocations China
Beijing China
United States--US
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 82103587
– fundername: Youth Program of Guangxi Natural Science Foundation of China
  grantid: 2020GXNSFBA159034
– fundername: National Natural Science Foundation of China
  grantid: 82003129, 82260499
– fundername: the Science and Technology Planned Project in Guilin
  grantid: 20210102-1
– fundername: Special Project Guangxi Science and Technology Base and Talent
  grantid: GUIKE AD20238031
– fundername: the Lijiang Scholar Award in Guilin
  grantid: 2022
– fundername: ;
  grantid: 2020GXNSFBA159034
– fundername: ;
  grantid: 2022
– fundername: ;
  grantid: GUIKE AD20238031
– fundername: ;
  grantid: 20210102-1
– fundername: ;
  grantid: 82003129, 82260499; 82103587
GroupedDBID ---
-5E
-5G
-A0
-BR
0R~
29K
2WC
3V.
4.4
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
ESX
F5P
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
AFGXO
ABVAZ
AFNRJ
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c595t-763c3e8aeda51ce997b44b3f760f3e982c07cbdeee0c4fb3fdefdf3a3bfcab4c3
IEDL.DBID RPM
ISSN 1756-9966
0392-9078
IngestDate Tue Oct 22 15:12:08 EDT 2024
Tue Sep 17 21:30:16 EDT 2024
Fri Aug 16 22:18:07 EDT 2024
Thu Oct 10 18:07:41 EDT 2024
Thu Feb 22 23:52:47 EST 2024
Fri Feb 02 04:18:52 EST 2024
Tue Aug 20 21:53:25 EDT 2024
Fri Sep 13 05:38:42 EDT 2024
Wed Oct 16 00:38:35 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HCC
Pre-metastatic niche
IL-1β
MMP9
SAA3
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c595t-763c3e8aeda51ce997b44b3f760f3e982c07cbdeee0c4fb3fdefdf3a3bfcab4c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339487/
PMID 37443052
PQID 2838783675
PQPubID 105475
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_517808f867e049aeb69f0a322ca8e02b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10339487
proquest_miscellaneous_2838250373
proquest_journals_2838783675
gale_infotracmisc_A757109209
gale_infotracacademiconefile_A757109209
gale_healthsolutions_A757109209
crossref_primary_10_1186_s13046_023_02748_4
pubmed_primary_37443052
PublicationCentury 2000
PublicationDate 2023-07-13
PublicationDateYYYYMMDD 2023-07-13
PublicationDate_xml – month: 07
  year: 2023
  text: 2023-07-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of experimental & clinical cancer research
PublicationTitleAlternate J Exp Clin Cancer Res
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References G Yu (2748_CR24) 2012; 16
S Mondal (2748_CR38) 2020; 194
SK Sharma (2748_CR16) 2015; 194
M Elkabets (2748_CR20) 2010; 40
2748_CR26
M Djurec (2748_CR33) 2018; 115
R Kaplan (2748_CR5) 2005; 438
Z Gong (2748_CR29) 2022; 34
X Yi (2748_CR32) 2019; 383
2748_CR28
H Peinado (2748_CR3) 2017; 17
D Kuang (2748_CR31) 2007; 110
W Lee (2748_CR15) 2019; 216
Y Liu (2748_CR4) 2016; 30
Z Wang (2748_CR9) 2022; 119
K Ganesh (2748_CR2) 2021; 27
ME Smoot (2748_CR25) 2011; 27
JT Erler (2748_CR6) 2009; 15
J Lee (2748_CR36) 2014; 44
D Padua (2748_CR11) 2008; 133
S Hiratsuka (2748_CR12) 2008; 10
P Ridker (2748_CR21) 2017; 390
Y Liu (2748_CR8) 2016; 30
C Reigstad (2748_CR34) 2009; 4
J Jang (2748_CR30) 2020; 80
E Voronov (2748_CR19) 2003; 100
S Hiratsuka (2748_CR40) 2002; 2
J Llovet (2748_CR1) 2021; 7
M Love (2748_CR22) 2014; 15
M Robinson (2748_CR23) 2010; 26
M Hansen (2748_CR35) 2015; 34
2748_CR17
2748_CR39
2748_CR10
A Mantovani (2748_CR18) 2018; 281
S Kim (2748_CR14) 2009; 457
D Aggen (2748_CR27) 2021; 27
HH Yan (2748_CR13) 2010; 70
W Zhou (2748_CR7) 2014; 25
Z Galis (2748_CR37) 2002; 90
References_xml – volume: 110
  start-page: 587
  year: 2007
  ident: 2748_CR31
  publication-title: Blood
  doi: 10.1182/blood-2007-01-068031
  contributor:
    fullname: D Kuang
– ident: 2748_CR39
  doi: 10.26508/lsa.201800226
– volume: 40
  start-page: 3347
  year: 2010
  ident: 2748_CR20
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201041037
  contributor:
    fullname: M Elkabets
– volume: 194
  start-page: 5529
  year: 2015
  ident: 2748_CR16
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1403215
  contributor:
    fullname: SK Sharma
– volume: 25
  start-page: 501
  year: 2014
  ident: 2748_CR7
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.03.007
  contributor:
    fullname: W Zhou
– volume: 30
  start-page: 243
  year: 2016
  ident: 2748_CR8
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.06.021
  contributor:
    fullname: Y Liu
– volume: 100
  start-page: 2645
  year: 2003
  ident: 2748_CR19
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0437939100
  contributor:
    fullname: E Voronov
– volume: 438
  start-page: 820
  year: 2005
  ident: 2748_CR5
  publication-title: Nature
  doi: 10.1038/nature04186
  contributor:
    fullname: R Kaplan
– volume: 16
  start-page: 284
  year: 2012
  ident: 2748_CR24
  publication-title: OMICS
  doi: 10.1089/omi.2011.0118
  contributor:
    fullname: G Yu
– volume: 44
  start-page: 1672
  year: 2014
  ident: 2748_CR36
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201343867
  contributor:
    fullname: J Lee
– volume: 70
  start-page: 6139
  year: 2010
  ident: 2748_CR13
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-0706
  contributor:
    fullname: HH Yan
– volume: 7
  start-page: 6
  year: 2021
  ident: 2748_CR1
  publication-title: Disease primers
  doi: 10.1038/s41572-020-00240-3
  contributor:
    fullname: J Llovet
– volume: 15
  start-page: 35
  year: 2009
  ident: 2748_CR6
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2008.11.012
  contributor:
    fullname: JT Erler
– volume: 4
  start-page: e5842
  year: 2009
  ident: 2748_CR34
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0005842
  contributor:
    fullname: C Reigstad
– volume: 216
  start-page: 176
  year: 2019
  ident: 2748_CR15
  publication-title: J Exp Med
  doi: 10.1084/jem.20181170
  contributor:
    fullname: W Lee
– volume: 457
  start-page: 102
  year: 2009
  ident: 2748_CR14
  publication-title: Nature
  doi: 10.1038/nature07623
  contributor:
    fullname: S Kim
– volume: 34
  start-page: 1960
  year: 2022
  ident: 2748_CR29
  publication-title: Cell Metabol
  doi: 10.1016/j.cmet.2022.11.003
  contributor:
    fullname: Z Gong
– volume: 115
  start-page: E1147
  year: 2018
  ident: 2748_CR33
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1717802115
  contributor:
    fullname: M Djurec
– volume: 27
  start-page: 608
  year: 2021
  ident: 2748_CR27
  publication-title: Clin cancer research: official J Am Association Cancer Res
  doi: 10.1158/1078-0432.CCR-20-1610
  contributor:
    fullname: D Aggen
– volume: 17
  start-page: 302
  year: 2017
  ident: 2748_CR3
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2017.6
  contributor:
    fullname: H Peinado
– ident: 2748_CR17
  doi: 10.1016/j.ccell.2021.04.011
– volume: 133
  start-page: 66
  year: 2008
  ident: 2748_CR11
  publication-title: Cell
  doi: 10.1016/j.cell.2008.01.046
  contributor:
    fullname: D Padua
– volume: 30
  start-page: 668
  year: 2016
  ident: 2748_CR4
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.09.011
  contributor:
    fullname: Y Liu
– volume: 10
  start-page: 1349
  year: 2008
  ident: 2748_CR12
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1794
  contributor:
    fullname: S Hiratsuka
– volume: 194
  start-page: 112260
  year: 2020
  ident: 2748_CR38
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2020.112260
  contributor:
    fullname: S Mondal
– volume: 90
  start-page: 251
  year: 2002
  ident: 2748_CR37
  publication-title: Circul Res
  doi: 10.1161/res.90.3.251
  contributor:
    fullname: Z Galis
– volume: 15
  start-page: 550
  year: 2014
  ident: 2748_CR22
  publication-title: Genome Biol
  doi: 10.1186/s13059-014-0550-8
  contributor:
    fullname: M Love
– volume: 34
  start-page: 424
  year: 2015
  ident: 2748_CR35
  publication-title: Oncogene
  doi: 10.1038/onc.2013.568
  contributor:
    fullname: M Hansen
– volume: 383
  start-page: 111454
  year: 2019
  ident: 2748_CR32
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2019.05.035
  contributor:
    fullname: X Yi
– volume: 281
  start-page: 57
  year: 2018
  ident: 2748_CR18
  publication-title: Immunol Rev
  doi: 10.1111/imr.12614
  contributor:
    fullname: A Mantovani
– volume: 2
  start-page: 289
  year: 2002
  ident: 2748_CR40
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(02)00153-8
  contributor:
    fullname: S Hiratsuka
– ident: 2748_CR28
  doi: 10.3390/cancers12020433
– volume: 27
  start-page: 34
  year: 2021
  ident: 2748_CR2
  publication-title: Nat Med
  doi: 10.1038/s41591-020-01195-4
  contributor:
    fullname: K Ganesh
– ident: 2748_CR26
  doi: 10.1016/j.semcancer.2022.05.002
– volume: 390
  start-page: 1833
  year: 2017
  ident: 2748_CR21
  publication-title: Lancet (London England)
  doi: 10.1016/S0140-6736(17)32247-X
  contributor:
    fullname: P Ridker
– volume: 26
  start-page: 139
  year: 2010
  ident: 2748_CR23
  publication-title: Bioinf (Oxford England)
  contributor:
    fullname: M Robinson
– volume: 27
  start-page: 431
  year: 2011
  ident: 2748_CR25
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq675
  contributor:
    fullname: ME Smoot
– volume: 119
  start-page: e2201899119
  year: 2022
  ident: 2748_CR9
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.2201899119
  contributor:
    fullname: Z Wang
– ident: 2748_CR10
  doi: 10.1016/j.immuni.2022.07.001
– volume: 80
  start-page: 1342
  year: 2020
  ident: 2748_CR30
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-19-2288
  contributor:
    fullname: J Jang
SSID ssj0061919
Score 2.4312217
Snippet Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the pre-metastatic...
Abstract Background Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how...
Background Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the...
BackgroundIncreasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the...
BACKGROUNDIncreasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how the...
Abstract Background Increasing evidence suggests a vital role of the pre-metastatic niche in the formation of distant metastasis of many cancers. However, how...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 166
SubjectTerms Analysis
Angiogenesis
Animals
Antibodies
Breast cancer
Carcinoma, Hepatocellular - pathology
Cloning
Flow cytometry
Genes
HCC
Hepatoma
Humans
IL-1β
Immunohistochemistry
Interleukin-1beta
Interleukins
Laboratory animals
Liver
Liver cancer
Liver Neoplasms - pathology
Lung - pathology
Lung cancer
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Matrix Metalloproteinase 9 - metabolism
Metastasis
Mice
MMP9
Ovarian cancer
Penicillin
Permeability
Plasmids
Pre-metastatic niche
RNA
RNA sequencing
SAA3
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-yB_EifltdNYLgQcq0TdKkx1FcFkHx4MLeQj7ZwZl2mc6A-6_sX7vvpZ0yxYMXr_Nehjbvu3nvF0I-sEb5ylubMyVczg3IwirBcyHLdOuoLFxC-_xRn1_wb5fi8uiqL-wJG-CBh41biFKqQkVVywDJrAm2bmJhQA2dUaGobPK-pTgUU4MPhqqgbA4jMqpe9CUeAOYQn_DMEj-hzcJQQuv_2ycfBaV5w-RRBDp7RB6OqSNdDo_8mNwL7RNy__t4OP6U3P7cr0GpzPaGIgjEdh32v1ctLakNO7MAVdtvqNlAgb7ydMmo-bPq6XXqxgs9XYPR0w0wQrbYA6GL9Aoi1a7DL_vYqkod3jrUdhtD7Q2Nxo3w3rAMckiK3STjcng82mKHKZ0mI5-Ri7Ovv76c5-PVC7kTjdjl4HUcC8oEb0TpQtNIy7llUdZFZKFRlSuksz6EUDgegeBD9JEZZqMzljv2nJy0XRteEuoDgt5HBpUb474y1sKf8gbk4HlVep6RTwdJ6OsBYUOnykTVepCbBrnpJDcN3J9RWBMnomOnH0Bn9Kgz-l86k5F3KGo9jJpONq6XUmBralU0GfmYONDKQeLOjMMK8EqIlzXjPJ1xgnW6OfmgTnr0Dr2GlE7h9IwUGXk_kXEldry1odsPPJCeMsky8mLQvumlmeSI1FZlRM30crYrc0q7ukrY4WXBWANF6qv_sY-vyYMq2ZTMS3ZKTnbbfXgDOdrOvk3meAcjDjx4
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3batRAdNAWxBfxbrTqCIIPEjbJTDKTJ9lKSxEsRSz0bZhb7NLdZN3sQvsr_VrPmcyuDYKvmTNhknOfcyPkI6ulK5wxKZOlTbkGXBhZ8rQUeZg6KjIbun2eVifn_NtFeREv3PqYVrmViUFQu87iHfkE1KDEigNRfln-TnFqFEZX4wiN-2S_yDmGafcPj07PfmxlMXgHYbQH6MgqRct-WzYjq0mfY1AwBZ2FcUy8VhupptDB_185fUdRjZMo72il48fkUTQn6XTA_xNyz7dPyYPvMWD-jNyebeZwcr26odgYYjX3m6tZS3Nq_FpPgPw2C6oX4LTPHJ0yqq9nPV2GDD3f0zkIAroAQLAge1joGnoJ2mvd4W0_pq9Si5OI2m6hqbmhjbax5TdsA7uSYoZJ3A7Hoy1mndJdteRzcn589PPrSRrHMaS2rMt1CpLIMi-1d7rMra9rYTg3rBFV1jBfy8Jmwhrnvc8sb2DB-cY1TDPTWG24ZS_IXtu1_hWhzmMj_IaBN8e4K7Qx8FJeAx4cL3LHE_J5iwm1HLpuqOCtyEoNeFOANxXwpgD6EJG1g8SO2eFBt_qlIgOqMhcyk42shAenSHtT1U2mQZxZLX1WmIS8R1Srofx0x_dqKkpMVy2yOiGfAgRyPmDc6ljAAJ-EPbRGkAcjSOBYO17ekpOKEqNXf-k7IR92y7gTs-Ba320GGDBZmWAJeTlQ3-6jmeDYva1IiBzR5eivjFfa2WXoJ55njNXguL7-_7nekIdF4BaR5uyA7K1XG_8WLLK1eRfZ7g8YuDep
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF9qBfFF_DZt1RUEHyQ2yW6ymweRUyxFqPjgQd-W_WwP75J6H9D7V_xrndnkQoN98fVmNlx2ZnZmsjO_IeQtq6UrnDEpk6VNuQZZGFnytBR5nDoqMhvRPr9Xp1P-7bw83yO7cUf9Bq5uTe1wntR0Of9w_Xv7CQz-YzR4WR2vcrzeS8H74I0kfiC7Q-4WnHHU-DM-3CpArhAHfYDHrFKM83dNNLc-Y-SoIp7_v6f2Dbc1Lqm84aNOHpIHfXBJJ502PCJ7vnlM7p311-dPyJ8fmzmonV5uKcJELOd-82vW0Jwav9bHoIybBdULSOFnjk4Y1dezFb2K9Xp-RedwLNAFMEI8uQJCG-gl-LJ1i9_-sZiVWpxL1LQLTc2WBm17AHBYBlEmxXqTfjn8PdpgDSodeiefkunJ159fTtN-OENqy7pcp3AuWeal9k6XufV1LQznhgVRZYH5WhY2E9Y4731meQCC88EFppkJVhtu2TOy37SNf0Go8wiLHxjkdoy7QhsDD-U1yMHxInc8Ie93klBXHQaHirmLrFQnNwVyU1FuCrg_o7AGTsTPjj-0ywvVm6MqcyEzGWQlPKRI2puqDpmGw81q6bPCJOQ1ilp1zajDKaAmosTi1SKrE_IucqBmgsSt7tsZ4JUQUWvEeTTiBPu1Y_JOndRO_RUEfRL7a0SZkDcDGVdiTVzj203HAwEsEywhzzvtG16aCY5YbkVC5EgvR7sypjSzy4gunmeM1ZDGHvzXrh-S-0U0HpHm7Ijsr5cb_xLCtbV5FW3wLzF4PSM
  priority: 102
  providerName: Scholars Portal
Title Pulmonary interleukin 1 beta/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation
URI https://www.ncbi.nlm.nih.gov/pubmed/37443052
https://www.proquest.com/docview/2838783675
https://search.proquest.com/docview/2838250373
https://pubmed.ncbi.nlm.nih.gov/PMC10339487
https://doaj.org/article/517808f867e049aeb69f0a322ca8e02b
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJCqWX0nfdplsVCj0UZ21LtuTjbkgIhQ1LaGDpRejZLF3byz6g-Sv9tR3J9hLTWy8-WCNje97SNyOEPpOSm8woFROe65hK4IXiOY1zloZTR1miQ7fP6-Lqln5b5IsjVPS1MAG0r9XyrF5VZ_XyLmAr15Ue9zix8Xx2niaElBBpj4_RMSOkz9Fb-wsZQTjOIwHPH0Pqx_tSGV6Mt6nfCIzBT_m9S7-UNnBHoWv_v7b5gXMaAicfeKLLZ-hpF0LiSfuqz9GRrV-gx7Nuk_wl-jPfr0C45OYe-2YQm5Xd_1rWOMXK7uQYRG5fYVlBor40eEKw_L3c4nVA5dktXoHy4woIIWrcwkDj8B14rF3jV_g9ZBVrf_pQ3VQSq3vspO7afMM0iCWxR5V00-H1cO2RpvhQIfkK3V5efD-_irsjGGKdl_kuBuujieXSGpmn2pYlU5Qq4liROGJLnumEaWWstYmmDgaMdcYRSZTTUlFNXqOTuqntW4SN9c3vHYEMjlCTSaXgobQEPhiapYZG6GvPCbFuO22IkKHwQrR8E8A3EfgmgHrqmXWg9F2yw41m81N0siLylPGEO14wC4mQtKooXSLBhGnJbZKpCH30rBZtyelB18WE5R6imiVlhL4ECq_twHEtu6IF-CTfN2tAeTqgBC3Vw-FenERnJbYCQjvuq2hYHqFPh2E_0yPfatvsWxoIUwkjEXrTSt_howmjvmNbFiE-kMvBXxmOgEqFHuK9Cr37_6nv0ZMsaBKLU3KKTnabvf0AEdpOjUAtF2yEHk0vruc3o7DOAdcZ5XC9mf4YBYX9C2V9Qyo
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,24346,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LjtMw0IJFAi6IN4GFNRISBxQ1iZ3YOaGCWBXYXXHYlXqz_Apb0SalaSX2V_haZpw0bITENTOOnMzbngchb1gpXeaMiZnMbcw10MLInMe5SMPUUZHY0O3zrJhd8C_zfN4fuLV9WuVeJwZF7RqLZ-QTMIMSKw5E_n79M8apUXi72o_QuEluccY48rmYDwEXxAZhsAdYyCJGv35fNCOLSZvilWAMFgtvMfFQbWSYQv_-f7X0NTM1TqG8ZpOO75N7vTNJpx31H5Abvn5Ibp_21-WPyO9vuyXsW2-uKLaF2Cz97seipik1fqsnwHy7FdUrCNkXjk4Z1b8WLV2H_Dzf0iWoAboCRPAfWwA0Fb0E27Vt8Kwfk1epxTlEdbPS1FzRStu-4TcsA6-SYn5Jvxy2R2vMOaVDreRjcnH86fzjLO6HMcQ2L_NtDHrIMi-1dzpPrS9LYTg3rBJFUjFfyswmwhrnvU8srwDgfOUqppmprDbcsifkoG5q_4xQ57ENfsUglmPcZdoYeCkvgQ6OZ6njEXm3p4Radz03VIhVZKE6uimgmwp0U4D9AYk1YGK_7PCg2XxXvfipPBUykZUshIeQSHtTlFWiQZlZLX2SmYgcIalVV3w6SL2aihyTVbOkjMjbgIFyDxS3ui9fgE_CDlojzMMRJsirHYP37KR6fdGqv9wdkdcDGFdiDlztm12HAw4rEywiTzvuGz6aCY6927KIyBFfjv7KGFIvLkM38TRhrISw9fn_93VE7szOT0_Uyeezry_I3SxIjohTdkgOtpudfwm-2da8CgL4B6zxOTA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgSBUb3o9AoUZCYoEyediJneVQqMqj1SyoVImFZTsOHXWSjCaJxPApfC3XTjJqYNdtfD2Kx8f3ER8fI_SWZDyPc6V8whPtUwlzoXhC_YRF7tZRFmqn9nmWnpzTLxfJxcCqbAZaZaXVclatylm1vHTcynWpg5EnFixOj6KQkAwy7WCdF8FtdAcWbczGSr33wlAXuEs9Qoj_PhSAfDwww9Ogiex2oA_Ryu5g2g9qk6DktPv_99DXQtSUPnktHh3fRz_GkfQ0lKtZ16qZ_v2PyOPNhvoA3RvSVDzvbR6iW6Z6hPZPh434x-jPolsBgOVmi63gxGZluqtlhSOsTCsDgHVXYlluV_Uyx3OC5a9lg9eO-WcavAIHg0swhMy0gYa6wJcQFdva7iJYWizW9oajqi4lVltcSD1IiUM3yFexZa4M3eH1cGXZrHh3CvMJOj_-9P3oxB-uefB1kiWtDx5OE8OlyWUSaZNlTFGqSMHSsCAm47EOmVa5MSbUtICG3BR5QSRRhZaKavIU7VV1ZZ4jnBsrsF8QqBIJzWOpFPwozWCWcxpHOfXQ-3GexbpX8xCuCuKp6FEhABXCoUKA9QcLhZ2lVeJ2D-rNTzFMkkgixkNe8JQZKLakUWlWhBLcpJbchLHy0KEFkuiPte78iZizxNJg4zDz0DtnYT0K4EnL4WAEDMlqc00sDyaW4An0tHkEqxg8USMgfeT2pA5LPPRm12x7WnZdZequt4FUmDDioWc9tneDJoxaVbjYQ3yC-sm_Mm0BLDud8hG7L27e9RDtLz4ei2-fz76-RHdjt2SZH5EDtNduOvMKEsJWvXYr_y9U6WJ1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulmonary+interleukin+1+beta%2Fserum+amyloid+A3+axis+promotes+lung+metastasis+of+hepatocellular+carcinoma+by+facilitating+the+pre-metastatic+niche+formation&rft.jtitle=Journal+of+experimental+%26+clinical+cancer+research&rft.au=Zhang%2C+Chong&rft.au=Li%2C+Qing&rft.au=Xu%2C+Qi&rft.au=Dong%2C+Wei&rft.date=2023-07-13&rft.issn=1756-9966&rft.eissn=1756-9966&rft.volume=42&rft.issue=1&rft_id=info:doi/10.1186%2Fs13046-023-02748-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13046_023_02748_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-9966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-9966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-9966&client=summon